This brilliant rainbow snake looks like something straight out of a fairytale! What's the science behind its magical iridescent sheen?

Florida’s Everglades is in crisis as the invasive Burmese python emerges as a new apex predator. These large constrictors have driven collapses in native prey: road surveys found raccoon sightings ...

The South Florida Water Management District's monthly python elimination competition has led to the removal of 279 snakes in ...

From reshaping creative industries to transforming high-risk fields, AI is opening doors to business models that were once too complex or costly to attempt. AI is creating new entrepreneurial ...

Opinions expressed by Entrepreneur contributors are their own. Ever feel stuck, wondering, “What business should I start?” That question traps more entrepreneurs than it helps. Here’s the truth: most ...

Florida couple Christina Kraus and Aaron Mann captured 87 invasive pythons from the Everglades in July, setting that month’s record and netting them thousands of dollars in payouts for helping remove ...

This Saturday, the Mountaineers will be trotting out a new starting quarterback for the first time this season, as Nicco Marchiol is on the shelf with a foot injury. Rolling in a new quarterback is ...

The Dream Chaser spaceplane, which has been under development for two decades, now seems like it might be further than ever from taking flight. On Thursday, NASA, confirming an earlier Ars Technica ...

Mom Thanks Taylor Swift for Honoring Late Son in 'Ruin the Friendship' Bengals vs. Steelers: Ja'Marr Chase becomes first NFL player in 28 years to pull off this improbable feat Do 1 Small Thing in ...

After an incredibly eventful summer, the Boston Celtics are going to look much different this season. They will have three new starters in the lineup after two straight seasons of being title ...

The special per diem rates that a taxpayer may use in substantiating travel and business expenses under the per diem substantiation method (set out in Rev. Proc. 2019-48) remain the same as the ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...